Metabolic conversion of IQ and MeIQ to bacterial mutagens.
The metabolic conversion of 2-amino-3-methyl- and 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoline (IQ and MeIQ respectively) to bacterial mutagens was studied using a bacterial mutation assay. Studies were performed using S9 fractions derived from either corn oil (uninduced) or Aroclor-1254-treated Sprague-Dawley rats. Aroclor 1254 treatment lowered the S9 protein concentration required for optimum levels of mutagenesis, enhanced the numbers of mutants observed and altered the effects of metabolic inhibitors and cofactors added to the assay. Studies with uninduced preparations revealed that IQ and MeIQ exhibited similar responses to the effects of metabolic inhibitors and cofactors involved in detoxication reactions. Both IQ and MeIQ activation appeared to be inhibited by the biogenic amines tryptamine and tyramine and inactivated by conjugation with either acetyl coenzyme A or glutathione.
D000105:Acetyl Coenzyme A / Q000494:pharmacology; D000818:Animals; D001711:Biotransformation / Q000187:drug effects; D004611:Ellipticines / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology; D008297:Male; D008713:Methimazole / Q000494:pharmacology; D008862:Microsomes, Liver / Q000378:metabolism*; D009153:Mutagens / Q000096:biosynthesis*; D011804:Quinolines / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012486:Salmonella typhimurium / Q000187:drug effects; D014363:Tryptamines / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D004611:Ellipticines; D007191:Indazoles; D009153:Mutagens; D011804:Quinolines; D014363:Tryptamines; C034192:ellipticine; C029216:2-amino-3-methylimidazo(4,5-f)quinoline; C030820:tryptamine; D008713:Methimazole; D000105:Acetyl Coenzyme A; C036989:2-amino-3,4-dimethylimidazo(4,5-f)quinoline; D014439:Tyramine